-- Days : -- HRS : -- MIN : -- SEC
Register Now →
News|Videos|April 28, 2025

Brad McElya, Pharm.D., on Preparation of a Drug Pipeline Talk. It Involves a 'Ton of Research' | Asembia's AXS25 Summit

In an interview with Managed Healthcare Executive, Brad McElya, Pharm.D., senior director, clinical pharmacy, at Walgreens, discusses the preparation that went into the drug pipeline talk he gave today at Asembia's AXS25 Summit in Las Vegas. McElya said his review about late-stage drug development would cover 140 drugs. He said he works with a team of six therapeutic area experts and also broader clinical teams at Walgreens. Preparing the talk involves a "ton of research," he said, that includes spending a lot of time on pharmaceutical company earnings calls. McElya emphasized the primacy of the patient. "It starts for us with the patient, understanding the unique needs of the patients and then, within that, the overall therapeutic area."

Related to this article

2.3 million reasons to rethink member communications before Jan. 1
CMS projects roughly 2.3 million people will lose Medicaid coverage in 2027 under the new community engagement requirements, also referred to as work requirements: four in ten to paperwork, not noncompliance. Arkansas showed how that happens; here is what plans can learn before the clock starts.